Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Suelen Scarpa de MelloMassachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.ORCID 0000-0001-6389-6041
Bailey SchultzHarvard Medical School, Microbiology Department, Harvard Medical School, Boston, Massachusetts, USA.
Byoungsook GohCenter for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Alexandra GroteDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Terrance SheaInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Jacob MuscatoBiology Department, Bowdoin College, Brunswick, Maine, USA.
Sungwhan F OhCenter for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Abigail L MansonInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0002-3800-0714
Ashlee M EarlInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0001-7857-9145
Suzanne WalkerHarvard Medical School, Microbiology Department, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-0545-914X
Ilana L B C CamargoGraduate Program in Immunology, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-4489-1215
Michael S GilmoreMassachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.ORCID 0000-0001-6389-832X
Funding
Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI CUOMO, CHRISTINA A · 2014 to 2024
$66.5M
Technical Mother Machine CoreP01AI083214 · NIAID · SCHEPENS EYE RESEARCH INSTITUTE · PI David C Hooper · 2009 to 2026
$39.4M
Gut symbiotic microbiota-derived CD1d ligands and their immunomodulatory mechanismsR01AI165987 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI OH, SUNGWHAN F · 2022 to 2025
$2.7M
Contribution of phytochemicals to gut symbiont colonization and synthesis of immunomodulatory sphingolipidsR01AT010268 · NCCIH · BRIGHAM AND WOMEN'S HOSPITAL · PI OH, SUNGWHAN F · 2019 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Loss of LafB activity reverses daptomycin resistance in · full record | OpenQuestion